Tim Forshew

researcher

Tim Forshew is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0003-2093-7020
P1153Scopus author ID6506634124

P108employerUniversity College LondonQ193196
P735given nameTimQ1369663
TimQ1369663
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q47992753Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.
Q29614797Analysis of circulating tumor DNA to monitor metastatic breast cancer
Q53078885Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.
Q43806776Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.
Q47931157Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro
Q40498502Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection.
Q81923030Identification of novel TYR and TYRP1 mutations in oculocutaneous albinism
Q37638497MAPK pathway activation and the origins of pediatric low-grade astrocytomas.
Q34734398MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas
Q36383975Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways
Q36852678Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.
Q24322437Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome
Q29620083Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Q34278191Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.
Q33975855Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.
Q41817199RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology
Q48206045RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort.
Q36961247Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complex
Q40067345Replication timing profile reflects the distinct functional and genomic features of the MHC class II region.
Q36800148Targeted therapy for BRAFV600E malignant astrocytoma.
Q36809583Three different brain tumours evolving from a common origin

Search more.